Eperezolid is an oxazolidinone antibiotic first patented in 1997 by Pharmacia & Upjohn. Although initially promising in clinical trials, it was found to be less effective than Linezolid, and a concerning pattern of Antimicrobial resistance had appeared, leading development to stop.
Synthesis
See also Linezolid
References